Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

App Lets Doctors Monitor Psychotic Patients’ Mental State, Treatment Adherence

November 30, 2015 By Asociación RUVID

Researchers at the Polytechnic University of Valencia have designed a new app that allows doctors to remotely monitor a psychotic outpatient’s mental state and improve overall adherence to treatment plans.

Collaborating with researchers from the INCLIVA institute for biomedical research, the team at the Universitat Politènica de València (Polytechnic University of Valencia, UPV) have already piloted the web and smartphone application which, among other things, reminds patients when they need to take their medication.

Currently a first prototype, the app is easy-to-use and requires minimal effort on the part of the patient. Using dialogue scripted by health care professionals, not only does it remind patients to take their medication, but it also periodically asks them a set of questions designed to elicit their mental state and feelings about the prescribed medication. Doctors, meanwhile, can program which questions are sent to each patient and monitor their answers online, giving them an overview of the patient’s mental health at all times. It also allows them to adjust the treatment plan in response to the patient’s feedback regarding the medication and its effects, refining dosage and daily doses as necessary.

The research is being lead by Ignacio Blanquer at the UPV’s I3M and Dr. Julio Sanjuán at INCLIVA, also reporting to the Spanish Networking Centre for Biomedical Research in Mental Health, CIBERSAM.

The team

Four Message Types and an Urgent Contact Button
Using the app, the patient receives four types of message: reminders, mood updates, side effects and feelings towards the medication. The first message type, the reminder, alerts the patient that it is time to take their medication: “The alert doesn’t necessarily have to coincide exactly with the time the medication needs to be taken, and there is also the option to ask the patient whether they took their last dose”, says David Arce, researcher at the UPV. Meanwhile, the mood update message asks patients how they are feeling at that precise moment; the side effects message is made up of a set of questions to check whether the patient is experiencing any adverse reactions to the medication; and the final message type comprises a set of statements designed to ascertain how well the patient is accepting their treatment.

Besides these messages, the app also includes a request urgent contact button for if they think they are experiencing an episode, which sends an alert to the doctor in real-time.

Monitoring patient responses

Pilot and Expected Impact of the App
The system was put to the test for two months at the Psychiatric Service at Valencia’s Hospital Clínico. One patient and two medical staff took part in this pilot. One of them, Dr. María José Escartí, a member of the project’s medical team and researcher at CIBERSAM, told us that “using the app allowed me to know the clinical state of the patient before they even arrived for their appointment, which meant I was better prepared to make decisions regarding their treatment going forwards”.

Psychosis is a condition of the mind described as involving a “loss of contact with reality”. It can range from relatively normal aberrant experiences through to more severe conditions such as schizophrenia and bipolar disorder, manifesting in the form of hallucinations, delusional beliefs and sometimes violence. Estimated adherence to treatment among patients prescribed oral medication is less than 60%, with 70% of psychotic patients abandoning treatment altogether within six months.

The idea is that, through the interactions prompted by this app and the resulting ad hoc adjustments to the treatment plan, overall adherence to treatment among these patients will be improved. The goal now is to integrate the information collected by the app into the patient’s clinical record.

Related Articles Read More >

DeepWell Digital Therapeutics Mike Wilson Ryan Douglas
How DeepWell is developing video games as tools for treating medical conditions
A woman with a small, handheld device in her lap with tubes that look like earphones plugged into her ears.
Ear-puffing device for migraine treatment wins FDA breakthrough designation
Abbott
Abbott launches upgraded digital health app for neurostimulation
Catheter delivery could enable better brain implants: Synchron’s neuroscience chief explains how

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech